Please wait...
About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Finding a Cure for Batten Disease
In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...
264%
funded
$5,000,000
next goal
7
lab notes
Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody...
Can we utilize natural bat colony behavior as a vaccination strategy?
Bats are one of the most prolific and ecologically important groups of mammals on the planet, but they are...
